HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai Zhao Selected Research

Ammonium Chloride (Sal Ammoniac)

9/2021N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan as Adjuvant Enhances the Immunogenicity of a VP2 Subunit Vaccine against Porcine Parvovirus Infection in Sows.
1/2020Water-soluble N-2-Hydroxypropyl trimethyl ammonium chloride chitosan enhanced the immunogenicity of inactivated porcine parvovirus vaccine vaccination on sows against porcine parvovirus infection.
1/2020Targeting delivery of partial VAR2CSA peptide guided N-2-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles for multiple cancer types.
1/2016Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.
10/2015O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai Zhao Research Topics

Disease

98Neoplasms (Cancer)
06/2022 - 07/2005
21Infections
06/2022 - 09/2010
19Inflammation (Inflammations)
06/2022 - 05/2011
17Neoplasm Metastasis (Metastasis)
01/2022 - 07/2005
16Glioma (Gliomas)
01/2021 - 11/2013
14Sepsis (Septicemia)
03/2022 - 05/2011
14Breast Neoplasms (Breast Cancer)
01/2020 - 03/2012
13Graft vs Host Disease (Graft-Versus-Host Disease)
06/2021 - 12/2013
12Stroke (Strokes)
05/2022 - 07/2009
11Glioblastoma (Glioblastoma Multiforme)
02/2022 - 07/2015
10Leukemia
01/2020 - 02/2011
7Hypoxia (Hypoxemia)
01/2022 - 05/2013
6Osteosarcoma (Osteogenic Sarcoma)
01/2019 - 01/2014
6Carcinogenesis
01/2018 - 10/2014
6Hepatitis B
04/2013 - 04/2003
5Prostatic Neoplasms (Prostate Cancer)
06/2022 - 02/2014
5Colitis
01/2022 - 09/2015
5Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 01/2017
5COVID-19
10/2021 - 01/2020
5Multiple Myeloma
01/2021 - 10/2014
5Virus Diseases (Viral Diseases)
01/2021 - 03/2015
5Bacterial Infections (Bacterial Infection)
01/2021 - 11/2018
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 05/2013
5Newcastle Disease
11/2017 - 01/2013
4Tics (Tic)
08/2021 - 01/2020
4Ischemic Stroke
08/2021 - 01/2019
4Brain Ischemia (Cerebral Ischemia)
01/2021 - 11/2008
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2015
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 09/2016
4Renal Cell Carcinoma (Grawitz Tumor)
04/2020 - 01/2014
4Dehydration (Water Stress)
01/2020 - 09/2013
4Body Weight (Weight, Body)
02/2018 - 10/2006
4Chronic Hepatitis B
06/2017 - 02/2007
4Melanoma (Melanoma, Malignant)
02/2014 - 03/2012
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2017
3Brain Injuries (Brain Injury)
01/2022 - 07/2009
3Infertility (Sterility)
01/2022 - 11/2016
3Diabetes Mellitus
01/2022 - 05/2015
3Reperfusion Injury
10/2021 - 12/2020
3Bone Resorption
08/2021 - 10/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 04/2020

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2010
18Pharmaceutical PreparationsIBA
08/2022 - 03/2008
18VaccinesIBA
10/2021 - 04/2005
16Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2012
12CytokinesIBA
01/2021 - 12/2013
11Small Interfering RNA (siRNA)IBA
02/2022 - 05/2013
11InflammasomesIBA
11/2021 - 01/2017
10RNA (Ribonucleic Acid)IBA
01/2022 - 08/2017
10MicroRNAs (MicroRNA)IBA
01/2021 - 01/2015
9Phosphotransferases (Kinase)IBA
02/2022 - 01/2018
9FlavonoidsIBA
01/2019 - 01/2011
8Messenger RNA (mRNA)IBA
06/2022 - 05/2013
8Therapeutic UsesIBA
01/2022 - 02/2007
8Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2014
7Transcription Factors (Transcription Factor)IBA
06/2022 - 03/2015
7ChitosanIBA
09/2021 - 11/2011
75,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
12/2019 - 03/2012
7Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2017 - 04/2003
6Long Noncoding RNAIBA
06/2022 - 12/2016
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2020 - 05/2013
6ElementsIBA
01/2020 - 09/2013
6Biological ProductsIBA
01/2019 - 07/2005
5AntibodiesIBA
07/2022 - 07/2008
5Testosterone (Sustanon)FDA Link
01/2022 - 02/2018
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2015
5CalciumIBA
10/2021 - 11/2009
5Ammonium Chloride (Sal Ammoniac)FDA Link
09/2021 - 10/2015
5Matrix Metalloproteinases (MMPs)IBA
06/2021 - 03/2012
5wogonosideIBA
10/2019 - 05/2013
5AntigensIBA
11/2017 - 07/2008
5Paclitaxel (Taxol)FDA LinkGeneric
08/2016 - 03/2008
4LipopolysaccharidesIBA
05/2022 - 04/2016
4Protein Kinases (Protein Kinase)IBA
02/2022 - 01/2019
4Oxygen (Dioxygen)IBA
01/2022 - 01/2016
4Indicators and Reagents (Reagents)IBA
06/2021 - 01/2016
4DNA VaccinesIBA
01/2020 - 01/2010
4Amino AcidsFDA Link
01/2020 - 12/2012
4Peptides (Polypeptides)IBA
01/2020 - 09/2011
4CateninsIBA
01/2020 - 12/2014
4ChromatinIBA
01/2019 - 05/2013
4Caspase 3 (Caspase-3)IBA
11/2018 - 10/2014
4Antiviral Agents (Antivirals)IBA
06/2017 - 03/2015
4wogoninIBA
01/2017 - 01/2014
4Bortezomib (Velcade)FDA Link
11/2016 - 01/2012
4Interleukin-22 (IL-22)IBA
10/2016 - 12/2013
3InterferonsIBA
07/2022 - 03/2015
3EndotoxinsIBA
03/2022 - 01/2022
3Competitive Endogenous RNAIBA
01/2022 - 01/2018
3Temozolomide (Temodar)FDA LinkGeneric
12/2021 - 04/2018
3Histones (Histone)IBA
10/2021 - 01/2012

Therapy/Procedure

27Therapeutics
01/2022 - 02/2011
12Drug Therapy (Chemotherapy)
02/2022 - 01/2017
6Hematopoietic Stem Cell Transplantation
06/2021 - 09/2014
5Radiotherapy
01/2021 - 01/2018
4Aftercare (After-Treatment)
01/2020 - 11/2013
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2016 - 12/2013
3Photothermal Therapy
02/2022 - 02/2014
3Immunotherapy
01/2022 - 11/2021
3Transplantation
10/2021 - 12/2018